Experimental analysis of eosinophil-associated gastrointestinal diseases

Current Opinion in Allergy and Clinical Immunology

Volumn 2, Issue 3, 2002, Pages 239-248

  Hogan, Simon P ^a   Foster, Paul S ^a   Rothenberg, Marc E ^a  

^a Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; INTERLEUKIN 5;

ALLERGY; CELL INFILTRATION; CELL MIGRATION; DISEASE ASSOCIATION; EOSINOPHIL; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; GRANULOCYTE; HUMAN; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0036277615     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200206000-00014     Document Type: Review

References (101)

1. The eosinophilic leukocyte: Structure and function
2. The immunobiology of eosinophils
3. Eosinophilia
4. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma). Inhibition by immunoglobulin A complexes
5. CD40 expression by human peripheral blood eosinophils
6. Lymph node trafficking and antigen presentation by endobronchial eosinophils
7. Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120
8. Intracellular localization of interleukin-6 in eosinophils from atopic asthmatics and effects of interferon gamma
9. The eosinophil: A cytokine-producing cell?
10. Food allergy. Part 1: Immunopathogenesis and clinical disorders
11. The role of the eosinophil in gastrointestinal diseases
12. Gastrointestinal eosinophils
13. Gastrointestinal eosinophils in health and disease
14. Eosinophilic gastroenteritis
15. Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: The Churg-Strauss syndrome
16. Cationic proteins of human eosinophils and their role in the inflammatory reaction
17. Cytotoxic effects of guinea pig major basic protein on tracheal epithelium
18. Cytotoxic properties of the eosinophil major basic protein
19. Mechanism of membrane damage mediated by human eosinophil cationic protein
20. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein
21. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: Homology with ribonuclease
22. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory viral pathogens
23. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins
24. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: A possible role for mast cells in late-phase allergic reactions
25. Eosinophil recruitment to the airway nerves
26. Gastric mucosal reactions in patients with food allergy
27. Eosinophil protein X and eosinophilic cationic protein as indicators of intestinal inflammation in infants with atopic eczema and food allergy
28. Immunoglobulin E and eosinophilic cationic protein in segmental lavage fluid of the small and large bowel identify patients with food allergy
29. Milk-sensitive and eosinophilic gastroenteropathy: Similar clinical features with contrasting mechanisms and clinical course
30. Activated eosinophils in familial eosinophilic gstroenteritis
31. Eosinophilic gastroenteritis: Ultrastructural evidence for a selective release of eosinophil major basic protein
32. Ultrastructural evidence for selective release of eosinophil major basic protein
33. Eosinophilic gastroenteritis: A clinicopathological study of patients with disease of the mucosae, muscle layer, and subserosal tissues
34. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease
35. Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: Cytotoxic potential in Crohn's disease
36. Eosinophilic gastroenteritis: A complex disease entity
37. Eosinophilic gastroenteritis
38. The eosiniophil in inflammatory bowel disease
39. Activated eosinophils in inflammatory bowel disease: Do they matter?
40. Infiltration of peroxidase-producing eosinophils into the lamina propria of patients with ulcerative colitis
41. Ultrastructural identification of exocytosis of granules from human gut eosinophils in vivo
42. Axonal necrosis of enteric autonomic nerves in continent ileal pouches: Possible implications for pathogenesis of Crohn's disease
43. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique
44. Milk-induced reflux in infants less than one year of age
45. Role of food protein intolerance in infants with persistent distress attributed to reflux esophagitis
46. Quantitative analysis of small intestinal mucosa in cow's milk-sensitive enteropathy
47. Interactions between food antigens and the immune system in the pathogenesis of gastrointestinal diseases
48. Colitis caused by food allergy in infants
49. Deposition of eosinophil-granule major basic protein and expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the mucosa of the small intestine in infants with cow's milk-sensitive enteropathy
50. Fecal tumor necrosis factor alpha, eosinophil cationic protein and IgE levels in infants with cow's milk allergy and gastrointestinal manifestations
51. Primary eosinophilic esophagitis in children: Successful treatment with oral corticosteroids
52. The spectrum of pediatric eosinophilic esophagitis beyond infancy: A clinical series of 30 children
53. Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis
54. Intraepithelial eosinophils: A new diagnostic criterion for reflux esophagitis
55. Eosinophil infiltration and degranulation in normal human tissue
56. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species
57. Selective induction of an immune response in human external secretions by ingestion of bacterial antigens
58. The role of digestive enzymes in orally induced immune tolerance
59. Antigen trafficking in the intestine
60. Oral tolerance: Mechanisms and applications: Introduction
61. Microencapsulation: The future of oral immunotherapy?
62. Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles
63. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy
64. A pathological role for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation
65. Peyer's patch eosinophils: Identification, characterization, and regulation by mucosal allergen exposure, interleukin-5, and eotaxin
66. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE
67. IgE and eosinophil regulation in a murine model of allergic aspergillosis
68. + Th2 lymphocyte function
69. Prospective study of colitis in infancy and early childhood
70. Allergic colitis in infancy: Clinical and pathologic aspects
71. Systemically derived large intestinal CD4+ Th2 cells play a central role in STAT-6-mediated allergic diarrhea
72. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract
73. Eosinophilic esophagitis attributed to gastroesophageal reflux: Improvement with an amino-acid based formula
74. An etiological role for aeroallergens and eosinophils in experimental esophagitis
75. Full thickness eosinophilia in oesophageal leiomyomatosis and idiopathic eosinophilic oesophagitis: A common allergic inflammatory profile?
76. Eosinophil function in health and disease
77. Chemokines and chemokine receptors: Their role in allergic airway disease
78. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells
79. The role of adhesion molecules in human eosinophil and basophil recruitment
80. Novel lymphocyte-specific CC chemokines and their receptors
81. Eotaxin-2, a novel cc chemokine that is selective for the chemokine receptor ccr3, and acts like eotaxin on human eosinophil and basophil leukocytes
82. Role of monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation
83. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils
84. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3
85. Eotaxin2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes
86. Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils
87. Murine eotaxin-2: A constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression
88. Murine eotaxin: An eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression
89. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung
90. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia
91. Eotaxin is required for the baseline level of tissue eosinophils
92. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the sites of inflammation
93. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics
94. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
95. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice
96. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow
97. + T-lymphocytes and interleukin-5 mediate atigen-induced eosinophil infiltration into the mouse trachea
98. Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice
99. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice
100. Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness
101. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization